These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1329 related articles for article (PubMed ID: 19426951)

  • 21. The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients.
    Beeri MS; Werner P; Davidson M; Noy S
    Int J Geriatr Psychiatry; 2002 May; 17(5):403-8. PubMed ID: 11994927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease: preventing and recognizing a misdiagnosis.
    Mangino M; Middlemiss C
    Nurse Pract; 1997 Oct; 22(10):58-9, 63-8, 70, passim. PubMed ID: 9355117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease.
    Zhu CW; Scarmeas N; Torgan R; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    Neurology; 2006 Sep; 67(6):998-1005. PubMed ID: 16914696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
    Fillit H; Hill JW; Futterman R
    Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild cognitive impairment in the general population: occurrence and progression to Alzheimer disease.
    Palmer K; Bäckman L; Winblad B; Fratiglioni L
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):603-11. PubMed ID: 18591580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden of Alzheimer's disease: population-based estimates and projections for New Zealand, 2006-2031.
    Tobias M; Yeh LC; Johnson E
    Aust N Z J Psychiatry; 2008 Sep; 42(9):828-36. PubMed ID: 18696288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated prevalence of Alzheimer's disease in the United States.
    Evans DA
    Milbank Q; 1990; 68(2):267-89. PubMed ID: 2233632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the costs of caring for people with Alzheimer disease in California: 2000-2040.
    Fox PJ; Kohatsu N; Max W; Arnsberger P
    J Public Health Policy; 2001; 22(1):88-97. PubMed ID: 11382092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study.
    Lopez OL; Kuller LH; Becker JT; Dulberg C; Sweet RA; Gach HM; Dekosky ST
    Arch Neurol; 2007 Mar; 64(3):416-20. PubMed ID: 17353386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies.
    Mitchell AJ; Shiri-Feshki M
    Acta Psychiatr Scand; 2009 Apr; 119(4):252-65. PubMed ID: 19236314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early diagnosis of Alzheimer's disease: clinical and economic benefits.
    Leifer BP
    J Am Geriatr Soc; 2003 May; 51(5 Suppl Dementia):S281-8. PubMed ID: 12801384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology of dependence in older people in Nigeria: prevalence, determinants, informal care, and health service utilization. A 10/66 dementia research group cross-sectional survey.
    Uwakwe R; Ibeh CC; Modebe AI; Bo E; Ezeama N; Njelita I; Ferri CP; Prince MJ
    J Am Geriatr Soc; 2009 Sep; 57(9):1620-7. PubMed ID: 19682135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive impairment.
    Joshi S; Morley JE
    Med Clin North Am; 2006 Sep; 90(5):769-87. PubMed ID: 16962841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacoeconomics of Alzheimer's disease.
    Fillit HM
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1139-44; discussion S1145-8. PubMed ID: 11142178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The growing burden of Alzheimer's disease.
    Lopez OL
    Am J Manag Care; 2011 Nov; 17 Suppl 13():S339-45. PubMed ID: 22214391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Net economic costs of dementia in Canada.
    Ostbye T; Crosse E
    CMAJ; 1994 Nov; 151(10):1457-64. PubMed ID: 7954140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessment of the cognitive, functioning and emotional impairments in patients with Alzheimer's disease in relation to lifestyle behaviours in the stage of life prior to the diagnosis of disease].
    Kaczmarek M; Skrzypczak M; Szwed A; Goździcka-Józefiak A; Geppert A
    Psychiatr Pol; 2008; 42(3):405-15. PubMed ID: 19899568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive impairment in older people: future demand for long-term care services and the associated costs.
    Comas-Herrera A; Wittenberg R; Pickard L; Knapp M
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):1037-45. PubMed ID: 17603823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism.
    Jellinger KA; Attems J
    Acta Neurol Scand; 2006 Jul; 114(1):38-46. PubMed ID: 16774626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mild cognitive impairment: a prodromal phase of dementia?].
    Jonker C; Comijs HC
    Tijdschr Gerontol Geriatr; 2007 Jul; 38(3):115-21. PubMed ID: 17642317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.